EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
2022 · Annals of the Rheumatic Diseases · 1,636 citations
https://doi.org/10.1136/ard-2022-223356
P
Peter Nash
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
572
Papers
28.3K
Citations
67
h-index
182
i10-index
Peter Nash is an academic researcher from Griffith University. The author has contributed to research in topics: Rheumatoid Arthritis Research and Therapies & Spondyloarthritis Studies and Treatments & Psoriasis: Treatment and Pathogenesis. The author has an h-index of 67, co-authored 487 publications.
ORCID: 0000-0002-2571-788XPapers by this author
worksTreating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
2015 · Annals of the Rheumatic Diseases · 1,431 citations
https://doi.org/10.1136/annrheumdis-2015-207524
Treatment recommendations for psoriatic arthritis
2008 · Annals of the Rheumatic Diseases · 558 citations
https://doi.org/10.1136/ard.2008.094946
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update
2024 · Annals of the Rheumatic Diseases · 283 citations
https://doi.org/10.1136/ard-2024-225531
Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial
2021 · Annals of the Rheumatic Diseases · 235 citations
https://doi.org/10.1136/annrheumdis-2020-219214
N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study
2012 · Arthritis Research & Therapy · 112 citations
https://doi.org/10.1186/ar3876
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat